28 results
Thumbnail

D3.70 - Structural and immunological insights into arginine kinases from house dust mites and related arthropods

Thumbnail

D3.63 - Molecular Evidence of PR-10 in Cannabis Allergy

Thumbnail

D3.64 - Alcohol-Soluble Wheat Proteins as the Likely Allergenic Trigger in a Patient With Reaction to Gin

Thumbnail

D3.66 - When dermatitis follows the menstrual cycle: two cases of endogenous progestogen hypersensitivity

Thumbnail

D3.67 - Retrospective Evaluation of IgE Panel Utility in Allergy Diagnostics: Insights from Baghdad, Iraq

Thumbnail

D3.71 - A research tool for development of in-house specific IgE immunoassays - comparison between different methods

Thumbnail

D3.72 - Effect of Helicobacter pylori Eradication on Disease Activity in Chronic Urticaria: Follow-Up Results

Thumbnail

D3.73 - Clinical Performance of Hycor NOVEOS–Based Specific IgE Measurements for the Screening of Respiratory Allergies

Thumbnail

D3.74 - Age-related characteristics of children's sensitisation to timothy grass according to component diagnostics

Thumbnail

D3.75 - Molecular sensitization profiles and clinical patterns in Albanian children with respiratory allergies

Thumbnail

D3.76 - Open-Label Clinical Trial To Evaluate The Effect Of Intranasal Olopatadine/Mometasone And Azelastine/Mometasone On Histamine Reactivity In Skin Prick Tests

Thumbnail

D3.77 - Tattoo Ink Allergy? Diagnostic Challenges in Cutaneous Reactions to Tattoo Ink Containing Metals

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project